EBI2 is a negative regulator of type I interferons in plasmacytoid and myeloid dendritic cells

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Chiang, Eugene Y ^a   Johnston, Robert J ^a   Grogan, Jane L ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7ALPHA,25 DIHYDROCHOLESTEROL; ALPHA INTERFERON; BETA INTERFERON; CD11B ANTIGEN; CHOLESTEROL DERIVATIVE; EPSTEIN BARR VIRUS INDUCED RECEPTOR 2; G PROTEIN COUPLED RECEPTOR; IMIQUIMOD; INTERFERON REGULATORY FACTOR 7; NUCLEIC ACID; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL ACTIVATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; IN VIVO STUDY; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; PERITONEUM; PLASMACYTOID DENDRITIC CELL; PROTEIN EXPRESSION; SPLEEN; WILD TYPE;

ANIMALS; CHEMOTAXIS; DENDRITIC CELLS; FEMALE; GENE EXPRESSION; INTERFERON REGULATORY FACTOR-7; INTERFERON TYPE I; LIGANDS; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, KNOCKOUT; MYELOID CELLS; PERITONEAL CAVITY; PERTUSSIS TOXIN; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SPLEEN; TOLL-LIKE RECEPTORS;

EID: 84893442028     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083457     Document Type: Article

References (51)

1. Bronson PG, Chaivorapol C, Ortmann W, Behrens TW, Graham RR (2012) The genetics of type I interferon in systemic lupus erythematosus. Curr Opin Immunol 24: 530-537.
2. Chiang CY, Engel A, Opaluch AM, Ramos I, Maestre AM, et al. (2012) Cofactors required for TLR7- and TLR9-dependent innate immune responses. Cell Host Microbe 11: 306-318.
3. Anwar MA, Basith S, Choi S (2013) Negative regulatory approaches to the attenuation of Toll-like receptor signaling. Exp Mol Med 45: e11.
4. Biron CA (1998) Role of early cytokines, including alpha and beta interferons (IFN-a/b), in innate and adaptive immune responses to viral infections. Semin Immunol 10: 383-390.
5. Colonna M, Trinchieri G, Liu YJ (2004) Plasmacytoid dendritic cells in immunity. Nat Immunol 5: 1219-1226. (Pubitemid 41057736)
6. Gilliet M, Cao W, Liu YJ (2008) Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8: 594-606.
7. Reizis B, Bunin A, Ghosh HS, Lewis KL, Sisirak V (2011) Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol 29: 163-183.
8. Marshak-Rothstein A (2006) Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6: 823-835.
9. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499-511. (Pubitemid 38931765)
10. Barbalat R, Ewald SE, Mouchess ML, Barton GM (2011) Nucleic acid recognition by the innate immune system. Annu Rev Immunol 29: 185-214.
11. Wang Y, Swiecki M, McCartney SA, Colonna M (2011) dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity. Immunol Rev 243: 74-90.
12. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, et al. (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777. (Pubitemid 44739521)
13. Ning S, Pagano JS, Barber GN (2011) IRF7: activation, regulation, modification and function. Genes Immun 12: 399-414.
14. Li Q, McDevitt HO (2011) The role of interferon alpha in initiation of type I diabetes in the NOD mouse. Clin Immunol 140: 3-7.
15. Li Q, Xu B, Michie SA, Rubins KH, Schreriber RD, et al. (2008) Interferon-alpha initiates type I diabetes in nonobese diabetic mice. Proc Natl Acad Sci USA 105: 12439-12444.
16. McBride JM, Jiang J, Abbas AR, Morimoto A, Li J, et al. (2012) Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: Results of a phase I, placebo-controlled, double-blind, dose-escalation study. Arthritis Rheum 64: 3666-3676.
17. Reynier F, Pachot A, Paye M, Xu Q, Turrel-Davin F, et al. (2010) Specific gene expression signature associated with development of autoimmune type-I diabetes using whole-blood microarray analysis. Genes Immun 11: 269-278.
18. van der Pouw Kraan TC, Wijbrandts CA, van Baarsen LG, Voskuyl AE, Rusternburg F, et al. (2007) Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis 66: 1008-1014.
19. van Baarsen LG, Wijbrandts CA, Rusternburg F, Cantaert T, van der Pouw Kraan TC, et al. (2010) Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment. Arthritis Res Ther 12: R11.
20. van Baarsen LG, Vosslamber S, Tijssen M, Baggen JM, van der Voort LF, et al. (2008) Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients. PLoS One 3: e1927.
21. Yao Y, Richman L, Morehouse C, de los Reyes M, Higgs BW, et al. (2008) Type I interferon: potential therapeutic target for psoriasis? PLoS ONE 3: e2737.
22. Mavragani CP, Crow MK (2010) Activation of the type I interferon pathway in primary Sjogren's syndrome. J Autoimmun 35: 225-231.
23. Rosenkilde MM, Benned-Jensen T, Andersen H, Holst PJ, Kledal TN, et al. (2006) Molecular pharmacological phenotyping of EBI2. An orphan seven-transmembrane receptor with constitutive activity. J Biol Chem 281: 13199-13208. (Pubitemid 43855231)
24. Gatto D, Paus D, Basten A, Mackay CR, Brink R (2009) Guidance of B cells by the orphan G protein-coupled receptor EBI2 shapes humoral immune responses. Immunity 31: 1-11.
25. Pereira JP, Kelly LM, Xu Y, Cyster JG (2009) EBI2 mediates B cell segregation between the outer and centre follicle. Nature 460: 1122-1126.
26. Hannedouche S, Zhang J, Yi T, Shen W, Nguyen D, et al. (2011) Oxysterols direct immune cell migration via EBI2. Nature 475: 524-527.
27. Liu C, Yang XV, Wu J, Kuei C, Mani NS, et al. (2011) Oxysterols direct B-cell migration through EBI2. Nature 475: 519-523.
28. Gatto D, Wood K, Caminschi I, Murphy-Durland D, Schofield P, et al. (2013) The chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells. Nat Immunol 14: 446-453.
29. Yi T, Cyster JG (2013) EBI2-mediated bridging channel positioning supports splenic dendritic cell homeostasis and particulate antigen capture. eLife 2: e00757.
30. Gatto D, Wood K, Brink R (2011) EBI2 operates independently of but in cooperation with CXCR5 and CCR7 to direct B cell migration and organization in follicles and the germinal center. J Immunol 187: 4621-4628.
31. Yi T, Wang X, Kelly LM, An J, Sailer AW, et al. (2012) Oxysterol gradient generation by lymphoid stromal cells guides activated B cell movement during humoral responses. Immunity 37: 535-548.
32. Heinig M, Petretto E, Wallace C, Bottolo L, Rotival M, et al. (2010) A transacting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature 467: 460-464.
33. Tang T, Li L, Tang J, Li Y, Lin WY, et al. (2010) A mouse knockout library for secreted and transmembrane proteins. Nat Biotechnol 28: 749-755.
34. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124: 783-801. (Pubitemid 43261452)
35. Swiecki M, Colonna M (2011) Type I interferons: diversity of sources, production pathways and effects on immune responses. Curr Opin Virol 1: 463-475.
36. Lafyatis R, Marshak-Rothstein A (2007) Toll-like receptors and innate immune responses in systemic lupus erythematosus. Arthritis Res Ther 9: 222.
37. Kehrl JH (1998) Heterotrimeric G protein signaling: roles in immune function and fine-tuning by RGS proteins. Immunity 8: 1-10.
38. Wang Y, Li Y, Shi G (2013) The regulating function of heterotrimeric G proteins in the immune system. Arch Immunol Ther Exp.
39. Pena JA, Thompson-Snipes L, Calkins PR, Tatevian N, Puppi M, et al. (2009) Alterations in myeloid dendritic cell innate immune responses in the Galphai2-deficient mouse model of colitis. Inflamm Bowel Dis 15: 248-260.
40. He J, Gurunathan S, Iwasaki A, Ash-Shaheed B, Kelsall BL (2000) Primary role for Gi protein signaling in the regulation of interleukin 12 production and the induction of T helper cell type 1 responses. J Exp Med 191: 1605-1610. (Pubitemid 30257356)
41. Cao W, Bover L, Cho M, Wen X, Hanabuchi S, et al. (2009) Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J Exp Med 206: 1603-1614.
42. Cao W, Rosen DB, Ito T, Bover L, Bao M, et al. (2006) Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J Exp Med 203: 1399-1405. (Pubitemid 43877601)
43. Cao W, Zhang L, Rosen DB, Bover L, Watanabe G, et al. (2007) BDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells. PLoS Biol 5: e248.
44. Rock J, Schneider E, Grun JR, Grutzkau A, Kuppers R, et al. (2007) CD303 (BDCA-2) signals in plasmacytoid dendritic cells via a BCR-like signalosome involving Syk, Slp65 and PLCgamma2. Eur J Immunol 37: 3564-3575.
45. Blasius AL, Cella M, Maldonado J, Takai T, Colonna M (2006) Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood 107: 2474-2476. (Pubitemid 43345570)
46. Liu YJ (2005) IPC: Professional type I interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23: 275-306.
47. Sozzani S, Vermi W, Del Prete A, Facchetti F (2010) Trafficking properties of plasmacytoid dendritic cells in health and disease. Trends Immunol 31: 270-277.
48. Umemoto E, Otani K, Ikeno T, Verjan Garcia N, Hayasaka H, et al. (2012) Constitutive plasmacytoid dendritic cell migration to the splenic white pulp is cooperatively regulated by CCR7- and CXCR4-mediated signaling. J Immunol 189: 191-199.
49. Asselin-Paturel C, Brizard G, Chemin K, Boonstra A, O'Garra A, et al. (2005) Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J Exp Med 201: 1157-1167. (Pubitemid 40528442)
50. Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL (2001) Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 159: 237-243. (Pubitemid 33704208)
51. Lande R, Giacomini E, Serafini B, Rosicarelli B, Sebastiani GD, et al. (2004) Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis. J Immunol 173: 2815-2824. (Pubitemid 39063143)